Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) constitute a paradigm shift in cancer therapy, and it has greatly expanded our knowledge of anticancer immunity and has introduced breakthroughs in cancer therapy. However, despite the promising results in the use of immunotherapy in some cancers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chyuan, I-Tsu, Chu, Ching-Liang, Hsu, Ping-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998672/
https://www.ncbi.nlm.nih.gov/pubmed/33801815
http://dx.doi.org/10.3390/cancers13061188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998672/
https://www.ncbi.nlm.nih.gov/pubmed/33801815
http://dx.doi.org/10.3390/cancers13061188

Ejemplares similares